相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling
Guanqun Ge et al.
TUMOR BIOLOGY (2016)
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li et al.
DRUG RESISTANCE UPDATES (2016)
Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism
Ann-Marie Meredith et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
Sai A. Balaji et al.
PLOS ONE (2016)
Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
William F. Penwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Importance of ABCC1 for cancer therapy and prognosis
Tereza Kunicka et al.
DRUG METABOLISM REVIEWS (2014)
Bactericidal effect of sulbactam against Acinetobacter baumannii ATCC 19606 studied by 2D-DIGE and mass spectrometry
Cheng-hao Lin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Structural diversity of ABC transporters
Josy ter Beek et al.
JOURNAL OF GENERAL PHYSIOLOGY (2014)
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
Kohji Noguchi et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2014)
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2013)
Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients
Syamhanin Adnan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
The expression profile of ATP-binding cassette transporter genes in breast carcinoma
Viktor Hlavac et al.
PHARMACOGENOMICS (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp PBP3
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance
Ji Yeon Yang et al.
BMC CANCER (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
Mechanisms and consequences of chemotherapy resistance in breast cancer
Helen M. Coley
EJC SUPPLEMENTS (2009)
ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome
Aaron M. Elliott et al.
MOLECULAR CANCER RESEARCH (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Multiple molecular mechanisms for multidrug resistance transporters
Christopher F. Higgins
NATURE (2007)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Multidrug resistance/P-glycoprotein and breast cancer: Review and meta-analysis
R Clarke et al.
SEMINARS IN ONCOLOGY (2005)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Predicting drug sensitivity and resistance:: Profiling ABC transporter genes in cancer cells
G Szakács et al.
CANCER CELL (2004)
Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer
HY Wang et al.
CANCER LETTERS (2003)
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic:: the role of hydrogen peroxide
SW Wang et al.
BIOCHEMICAL JOURNAL (2002)
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem
AS Levin
CLINICAL MICROBIOLOGY AND INFECTION (2002)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
